Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/4640
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Çolakoğlu, Murat | - |
dc.contributor.author | Yaylalı, Güzin Fidan | - |
dc.contributor.author | Colakoglu, N.Y. | - |
dc.contributor.author | Yılmaz, Mustafa | - |
dc.date.accessioned | 2019-08-16T11:35:48Z | - |
dc.date.available | 2019-08-16T11:35:48Z | - |
dc.date.issued | 2006 | - |
dc.identifier.issn | 0036-5548 | - |
dc.identifier.uri | https://hdl.handle.net/11499/4640 | - |
dc.identifier.uri | https://doi.org/10.1080/00365540500321405 | - |
dc.description.abstract | Standard treatments for visceral leishmaniasis (antimonials, amphotericin B and pentamidine) pose several problems. Failure of antimonials or severe toxicity is particularly troublesome in patients with renal insufficiency. We report a case of visceral leishmaniaisis and renal insufficiency successfully treated with fluconazole and allopurinol for 4 months. © 2006 Taylor & Francis. | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | Scandinavian Journal of Infectious Diseases | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | allopurinol | en_US |
dc.subject | amphotericin B | en_US |
dc.subject | fluconazole | en_US |
dc.subject | pentamidine | en_US |
dc.subject | adult | en_US |
dc.subject | antibody titer | en_US |
dc.subject | article | en_US |
dc.subject | diabetes mellitus | en_US |
dc.subject | diabetic nephropathy | en_US |
dc.subject | disease association | en_US |
dc.subject | drug efficacy | en_US |
dc.subject | enzyme linked immunosorbent assay | en_US |
dc.subject | human | en_US |
dc.subject | kidney failure | en_US |
dc.subject | laboratory diagnosis | en_US |
dc.subject | laryngitis | en_US |
dc.subject | male | en_US |
dc.subject | pharyngitis | en_US |
dc.subject | visceral leishmaniasis | en_US |
dc.subject | Allopurinol | en_US |
dc.subject | Animals | en_US |
dc.subject | Antimetabolites | en_US |
dc.subject | Antiprotozoal Agents | en_US |
dc.subject | Diabetic Nephropathies | en_US |
dc.subject | Drug Therapy, Combination | en_US |
dc.subject | Fluconazole | en_US |
dc.subject | Humans | en_US |
dc.subject | Kidney Failure | en_US |
dc.subject | Leishmaniasis, Visceral | en_US |
dc.subject | Male | en_US |
dc.subject | Middle Aged | en_US |
dc.subject | Treatment Outcome | en_US |
dc.title | Successful treatment of visceral leishmaniasis with fluconazole and allopurinol in a patient with renal failure | en_US |
dc.type | Article | en_US |
dc.identifier.volume | 38 | en_US |
dc.identifier.issue | 3 | en_US |
dc.identifier.startpage | 208 | en_US |
dc.identifier.endpage | 210 | en_US |
dc.authorid | 0000-0003-0012-4700 | - |
dc.identifier.doi | 10.1080/00365540500321405 | - |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.identifier.pmid | 16500783 | en_US |
dc.identifier.scopus | 2-s2.0-33644599787 | en_US |
dc.identifier.wos | WOS:000235553800010 | en_US |
dc.identifier.scopusquality | Q3 | - |
dc.owner | Pamukkale_University | - |
item.fulltext | No Fulltext | - |
item.languageiso639-1 | en | - |
item.openairetype | Article | - |
item.cerifentitytype | Publications | - |
item.grantfulltext | none | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
Appears in Collections: | PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
CORE Recommender
SCOPUSTM
Citations
4
checked on Nov 16, 2024
WEB OF SCIENCETM
Citations
4
checked on Nov 14, 2024
Page view(s)
46
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.